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Abstract   
 
Porcine endogenous retroviruses (PERVs) represent a risk for xenotransplantation using pig cells or 
organs since they are integrated in the genome of all pigs and infect human cells in vitro. 
Recombinants between PERV-A and PERV-C have been described in pigs in vivo and found de novo 
integrated in the genome of somatic cells, but not in the germ line. To study whether PERV-A/C can 
infect and have a pathogenic effect in normal pigs, German landrace pigs were inoculated with high-
titre PERV-A/C. No provirus integration was found in blood cells or in various tissues, and no antibody 
production was observed, indicating the absence of infection.  
 
Xenotransplantation may help to overcome the shortage of allotransplants. However, the 
transplantation of cells, tissues or organs from pigs to humans may be associated with transmission of 
zoonotic porcine microorganisms. Porcine endogenous retroviruses (PERVs) represent a special risk, 
since they are integrated in the genome of all pigs, are released by normal pig cells and infect human 
cells in vitro (for review see Ref. [1]). Whereas PERV-A and PERV-B are human/polytropic viruses 
and are present in the genome of all pigs, PERV-C are ecotropic viruses and are present only in some 
pigs. Recombinants between PERV-A and PERV-C have been reported, which were generated in pigs 
in vivo and which were found de novo integrated in the genome of some pig cells, but not in the germ 
line, indicating that recombination took place during the lifetime of the animals [2–6]. PERV-A/C are 
characterised by high titres when compared with parental PERV-A [7], and when propagated on 
human cells, the titre increases further due to multimerisation of transcription factor NFY binding sites 
in the long terminal repeats (LTR) [8]. Similar changes in the LTR were observed, when PERV-A was 
propagated in human cells [8–10].  
It is still unclear whether PERVs are associated with pathogenesis in pigs. PERVs have been isolated 
from a cell line derived from a malignant lymphoma [11], and an elevated expression of PERV in pig 
melanoma cells compared with the expression in normal skin cells has been reported [12], but it is 
unclear whether the virus was involved in tumour development. On the other hand, PERV particles 
have been isolated from normal pig kidney cell lines [13, 14]. In addition, integrated PERV-A/C has 
been detected in the spleen, but not in other organs, of animals with melanoma [12]. In order to 
analyse whether PERV-A/C can infect normal pigs and whether this infection has pathologic 
consequences, pigs were inoculated with high doses of PERV/50. This virus was derived from a 
recombinant PERV-A/C, called PERV/30 (kindly provided by C. Wilson [2]), which was passaged 
serially on human 293 cells. During the passages, the titre increased and an increase in the number of 
transcription factor NFY binding sites in the LTR was observed [8]. A 37-bp sequence containing the 
NFY binding site ATTGG is present once in PERV/3o, twice in PERV/4o and 5 times in PERV/5o [8]. 
After long-term cultivation on human 293 cells without selection pressure (e.g., without passaging onto 
uninfected 293 cells) the cells produced a mixture consisting of PERV-5o and PERV/LT (long term) 
characterised by the loss of two NFY binding sites and one CCAAT protein (CBEP) binding site by 
deletion [15].  
Pigs were inoculated with the supernatant of 293 cells producing a mixture of PERV/5o and PERV-LT. 
In order to characterize the proviruses, cellular DNA was isolated (DNeasy Blood and Tissue Kit, 
QIAGEN) and PCR was performed using the primer pairs PERVenvAfor 
(TGGAAAGATTGGCAACAGCG) and rev (AGTGATGTTAGGCTCAGTGG) [16] and LTRfor 
  
(TCTTGGTGACAACATGTCTC) and rev (AGTGTGGAGTCGGGACAGCT) [15]. Electrophoresis was 
performed in a 1% agarose gel. As expected, analysis of the LTR showed that a mixture of PERV/50 
and PERV/LT had been produced (Fig. 1). Five hundred ml of viral supernatant corresponding to 
6.4 × 106 infectious particles, as shown by titration on 293 cells, were inoculated i.p. into each of two 
German landrace pigs (#5 and #17) obtained from a farm in Germany. To measure the virus titer, 293 
cells were cultured in microtiter plates (1.5 × 105 cells/well), dilutions of virus-containing supernatant 
were added, and after 72 h, DNA was collected after cell lysis by freezing/thawing and treatment with 
proteinase K. Proviral DNA was quantified by real-time PCR using the gag primers 
TCCAGGGCTCATAATTTGTC and TGATGGCCATCCAACATCGA and the probe FAM-
AGAAGGGACCTTGGCAGACTTTCT-BHQ1. A duplex PCR was performed using primers and a 
probe specific for GAPDH (GGCGATGCTGGCGCTGAGTAC, TGGTCCACACCCATGACGA, HEX-
TTCACCACCATGGAGAAGGCTGGG-BHQI). The ∆Ct method was used to normalise PERV 
integration to the GAPGH gene copy number, and neutralisation was expressed as percent inhibition 
of provirus integration by the immune serum compared with the preimmune serum.  
 
A third animal (#6) was kept as a negative control. Like all pigs, animals 5, 6 and 17 carried PERV-A 
(Fig. 2) and PERV-B (not shown) in their genome, as shown by PCR. They did not carry PERV-C and 
were therefore unable to generate PERV-A/C. Blood was taken from the animals 1, 2, 3 and 4 months 
after inoculation and analysed for the presence of PERV-A/C by PCR using the primers PERV-A 
VRBF (CCTACCAGTTATAATCAATTTAATTATGGC) and PERV-C env TMR 
(CTCAAACCACCCTTGAGTAGTTTCC) [3]. This PCR recognizes 0.00026 copies per cell, as 
estimated by dilution of a PERV-A/C plasmid with pig DNA. After four months, the animals were 
sacrificed, organs were taken, and the DNA was isolated and analysed for the presence of PERV-A/C 
(Fig. 2). PERV-A/C was not detected in any of the samples, indicating that the virus did not infect 
either animal. To study whether PERV-specific antibodies were produced, lysates of PERV-A/C 
particles pelleted by ultracentrifugation through a sucrose cushion were used, and proteins were 
subjected to SDS-PAGE in 10% gels using a tricine-buffered system [17] and transferred to PVDF 
membranes (Millipore, Bedford, MA, USA) by semidry electroblotting. Nonspecific binding was blocked 
using 0.05% Tween 20 and 5% milk in PBS for 1 hour at room temperature. Sera from pigs after 
inoculation of PERV-A/C were used at a 1:100 dilution, goat sera specific for the transmembrane 
envelope protein p15E (#355), for the core protein p27Gag (#14 [18]) and for the surface envelope 
protein gp70 (#62 [19]) were used at a 1:250 dilution (Fig. 3). No antibodies were detected, indicating 
the absence of infection.  
Despite the fact that PERV-A/C infects pig Iowa cells in vitro (not shown), the result of the experiment 
demonstrate that this virus is not easily transmissible from one pig to another, and this is in agreement 
with previous studies showing that it is difficult to infect animals with PERV. Although mink cells [20] 
and cells from non-human primates [21–23] can be infected with PERV in vitro, all attempts to infect 
animals in vivo have failed: provirus integration and PERV-specific antibodies were not detected in 
minks [20] or in baboons, pig-tailed macaques and rhesus monkeys inoculated with high-titre PERV50 
and treated daily with three different immunosuppressive drugs [23].  
How can the absence of infection be explained? First, pigs may express PERV-A Env proteins in their 
tissues and prevent infection with PERV-A/C due to receptor interference. Second, PERV may be 
eliminated by innate immunity. The complement system and preformed antibodies may be involved in 
this process [24, 25]. In addition, intracellular restriction factors may prevent virus replication [26–28]. 
Third, the amount of virus used for inoculation may have been too low. However, the number of 
infectious particles (6.4 × 106) was much higher than what has been used for infection of cats with 
feline leukaemia virus (FeLV) and mice with murine leukaemia virus (MuLV). Between 1 × 104 TCID50 
[29] and 1 × 106 ffu [30] FeLV was sufficient to infect cats oronasally, and 2 × 104 ffu was used for 
successful infection of mice with MuLV [31]. The absence of antibodies may be explained either by the 
absence of replication or by the fact that pigs are immunologically tolerant to PERVs, as they are 
endogenous. Since PERV-C-free animals were used in these studies, this tolerance has to include 
closely related Env sequences of PERV-C. On the other hand, antibodies against the human 
endogenous retrovirus HERV-K, which is endogenous in humans, have been found in patients 
expressing HERV-K in melanomas [32].  
The negative results of the infection experiments, including those described here using high-titre 
PERV, may explain the absence of infection in pig-to-non-primate xenotransplantations as well as in 
the first clinical xenotransplantations, which included liver failure patients receiving ex vivo perfusions 
of porcine hepatocytes, and also in butchers, who often have blood-blood contact with pigs (for review 
  
see Ref. [33]).  
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Figure 1. Characterisation of the LTR of the virus used for inoculation. 1-3 control plasmids, 1- PERV-
3o, containing one 37-bp sequence, which contains the NFY binding site, 2- PERV-4o, containing two 
37-bp sequences, 3- PERV-5o containing 5 of the 37-bp sequences, 4- 293 cells infected with PERV-





















Figure 2. PCR analysis of pigs before and at different time points after inoculation with PERV-A/C as 
well as of the organs of animal 17, using primers specific for PERV-A/C and PERV-A. Animal 6 was 
untreated (not tested in month 0), and animals 5 and 17 received PERV-A/C. 1 - heart, 2 - muscle, 3 - 









Figure 3. Western blot analysis of sera from three pigs collected four months after inoculation with 
PERV-A/C. Animals 5 and 17 were inoculated; animal 6 was the control. As antigen a lysate of purified 
PERV-5o was used; the sera were diluted 1:100. 1 - Goat sera against p15E, 2 - gp27Gag and 3 - 
gp70, 4 - pig 6, 5 - pig 5, 6 - pig 17. In lane C, the immune response of a pig against E. coli lysate is 
shown, demonstrating the functionality of the anti-pig antibody  
 
 
 
 
 
  
